Preprint
Article

This version is not peer-reviewed.

Characterization of the Non-Volatile Fraction of the Edible and Medicinal Halophyte Sea Mayweed (Tripleurospermum maritimum L.)

Submitted:

05 March 2025

Posted:

05 March 2025

You are already at the latest version

Abstract
Sea mayweed (Tripleurospermum maritimum L. syn. Matricaria maritima) is an edible species widely distributed along the Atlantic shoreline. Unlike other Tripleurospermum species, the chemical composition and biological activities of this halophyte have received little attention. Here, a hydroalcoholic extract of sea mayweed leaves was evaluated for in vitro antioxidant (DPPH, ABTS, and FRAP bioassays), anti-inflammatory (NO reduction in RAW 264.7 macrophages), anti-diabetic (alpha-glucosidase inhibition), neuroprotective (inhibition of acetylcholinesterase), and skin protective (tyrosinase, melanogenesis, elastase and collagenase inhibition) activities. Solid-liquid partition chromatography of the extract and NMR characterization of its fractions allowed the purification of some major compounds, including fructo-oligosaccharides in the MeOH20 fraction, a new carbohydrate called tripleurospermine (1) and 3-5-dicaffeoylquinic acid (2) in the MeOH40 fraction, and matricaria lactone (3) in the MeOH80 fraction. Both (1) and (2) compounds exhibited strong antioxidant and anti-tyrosinase activities, and (3) showed anti-inflammatory and anti-diabetic potential. Overall, our results suggest that sea mayweed may have dietary or medicinal uses due to its bioactive substances.
Keywords: 
;  ;  ;  ;  ;  ;  

1. Introduction

The Matricaria and Tripleurospermum genera have long been considered synonymous within the Asteraceae (Compositae) family. Recently, they have been separated in two closely related taxa in the Anthemideae tribe [1,2]. Together, these two genera consist of about 40 species widely distributed in Europe, North Africa, America, and temperate Asia. Matricaria species are often used for ornamental, medicinal or feeding purposes, whereas Tripleurospermum do not have much uses yet. Over the past decade, many pharmacological properties have been described in Matricaria genus, including anti-inflammatory [3,4], anti-tumoral, antioxidant, neuroprotective [5], anti-allergic [6], antimicrobial [7,8], anticancer [9], sedative, stomachic, antispasmodic, as well as antidiarrheal activities [10].
So far, a number of studies have examined the chemical composition of some members of Matricaria or Tripleurospermum, especially of their essential oils [11,12]. In addition, valuable secondary metabolites such as phenolic compounds [13,14,15] and related coumarins [16,17], terpenes [18], and polyacetylenes were identified (see [19] as a review). However, only a few Tripleurospermum species have been phytochemically investigated so far, including T. auriculatum or T. disciforme [20,21,22], whereas little or no information is available about most species including T. maritimum.
Tripleurospermum maritimum (L.) W.D.J. Koch (previously Matricaria maritima L.) is a biennial halophytic plant. Commonly known as false mayweed or sea mayweed, it grows along the Atlantic coast of Europe, mostly on sandy beaches and pebbles. Alternatively, it can be easily grown in open field by standard agronomic techniques (Figure 1), yielding about 1.2 TDW/ha-1 (Magné, unpublished data).
We previously reported that T. maritimum leaves contain a large amount of fructo-oligosaccharides [23], which are the major components of a water extract. Here, we describe the isolation and structural characterization of several major constituents of sea mayweed, and evaluate several biological activities of nutraceutical and cosmetic interest.

2. Results

2.1. Total Phenolic Content

The crude extract of T. maritimum exhibited a high phenolic amount, with 22.1 mg GAE.g-1DW (Figure 2). After fractionation of sea mayweed leaf extract, phenolics were detected mainly in the fractions eluted with 20, 40, 60, and 80% methanol, which exhibited 3.2, 4.3, 2.2, and 1.9 times more phenolic compounds than the crude extract, respectively.

2.2. Antioxidant Activities

The crude extract of T. maritimum exhibited high reducing activity, with EC50 value of 0.153 mg.mL-1 for FRAP bioassay (Figure 3A). After fractionating the extract, the MeOH20, MeOH40, MeOH60, and MeOH80 fractions exhibited the highest reducing capacity, with EC50 values 5, 8.9, 7.5 and 2.6 times lower than that of the crude extract, respectively. The same trend was observed in the DPPH assay, where MeOH20, MeOH40, MeOH60, and MeOH80 fractions showed IC50 values 4.5, 5, 7, and 3.2 times lower than that of the crude extract (0.129 mg.mL-1), respectively (Figure 3B). Similarly, the ABTS radical scavenging capacity was distributed among the fractions eluted with methanol solutions. Thus, MeOH20, MeOH40, MeOH60, MeOH80, and MeOH100 fractions exhibited 6.7, 13.5, 6.3, 6.8, and 4 times higher activities than the crude extract (62 mg TE.g-1DW), respectively (Figure 3C). Conversely, the last fraction (eluted with ethyl acetate) showed negligible or no activities using every antioxidant bioassay.

2.3. Other Biological Activities

2.3.1. Anti-Ageing Activity

Sea mayweed crude extract exhibited an appreciable activity against tyrosinase, with a value of 234 mg KAE.g-1 DW. Of the seven fractions eluted from this extract, the last five exhibited a significantly higher activity than that of the crude extract (P < 0.05) (Table 1). Among them, the MeOH100 and ethyl acetate fractions were the most active with around 700 mg KAE.g-1 DW. Moreover, a mild anti-melanogenic action on B16 4A5 melanoma cells was found in the last fraction (eluted with ethyl acetate), though being less active than the standard (arbutin).

2.3.2. Anti-Inflammatory Activity

Although sea mayweed raw extract did not show any capacity to inhibit NO production by RAW 264.7 macrophages, two of its fractions (namely MeOH60 and MeOH80) were able to reduce strongly this indicator of inflammation (Table 1). Noteworthy, the fraction eluted with 60% and 80% MeOH exhibited a remarkable NO inhibitory power, with an IC50 value five and three times lower than that of the positive control L-NAME (27.81 μg.mL-1), respectively.

2.3.3. Neuroprotective Activity

Sea mayweed extract and fractions were evaluated for their capacity to inhibit AChE, the primary enzyme responsible for the hydrolytic metabolism of the neurotransmitter acetylcholine. However, only MeOH60 fraction exhibited a slight inhibitory effect on AChE (Table 1).

2.3.4. Antidiabetic and Anti-Obesity Activities

Pancreatic lipase is the enzyme responsible for digestion and absorption of triglycerides, and its inhibition is one of the widest studied methods to determine the potential activity of natural products to prevent and treat obesity. Here, neither extracts nor fractions showed inhibitory activity on rat lipase enzyme in vitro. Then, their capacity to inhibit α-amylase and α-glucosidase was assessed. Although sea mayweed raw extract was inactive on these enzymes, four fractions strongly inhibited α-glucosidase: MeOH40, MeOH60, MeOH80, and ethyl acetate fractions (Table 1). Of these, MeOH60 and ethyl acetate fractions exhibited a remarkable inhibitory effect, with 50 and 150-fold lower IC50 values than the standard glucosidase inhibitor acarbose. Besides, no amylase inhibition could be detected in these fractions.

2.4. Solute Identification

Following purification of the extract, the characterization of the active fractions was performed by NMR spectroscopy. The 1H-NMR spectrum of the water fraction (effluent) showed mainly the presence of numerous signals from oses and amino-acids (Figure 4A). Major signals, assigned to fructo-oligosaccharides, were found in the MeOH20 fraction (Figure 4B). The 1H-NMR spectrum of the MeOH40 fraction exhibited numerous signals in the aliphatic (1.8-2.8 ppm), anomeric (3.2-4.6 ppm), and unsaturated (5.5-7.6 ppm) regions (Figure 4C). Further examination of this fraction, following sub-fractionation and subsequent 13C- and 2D NMR analyses, allowed us to obtain a pure compound in the subfraction eluted with 20% MeOH. This compound was characterized by signals between 3.2 and 4.2 ppm associated with a doublet in the anomeric region (4.5 ppm), suggesting a sugar residue. Other signals in the unsaturated (5.5 and 6.1 ppm) and aliphatic (from 1.8 to 2.8 ppm) regions were also identified, and 2D-NMR COSY and TOCSY experiments showed two spin systems (supplementary data). The first one was characterized by signals at 4.56 (H1, d), 3.29 (H2, dd), 3.47 (H3, m), 3.39 (H4, m), 3.43 (H5, m), 3.71 (H6a, m) and 3.90 (H6b, m) ppm. Corresponding carbons were identified by means of a HMQC experiment at 105.42, 76.1, 78.5, 72.4, 79, and 63.7 ppm, respectively. The second spin system was characterized by signals at 1.85 (H1’, dd), 6.06 (H2a’, m), 5.49 (H3’, dd), 2.76 (H6’, d), 3.92 (H7’), 1.98 (H8’, m), and 2.32 (H9’, t) ppm. These protons could be correlated by HMQC experiment to carbons at 18.1, 142, 111, 28.4, 82, 32.9, and 36.1 ppm, respectively. Examination of J-MOD spectrum suggested that the first spin system belongs to a sugar residue, and HMBC experiments allowed us to correlate this residue to the second spin system. Finally, acid hydrolysis of this subfraction provided a glucose residue, and 2D NMR experiments showed that the lateral chain corresponded to dec-8-ene-6-ynoic acid (Figure 5). This observation was confirmed by mass spectrometry analysis, and the purified structure was identified as 4-O--D glucose derivative of dec-8-ene-6-ynoic acid (Figure 6A). This newly reported compound was named tripleurospermine. Moreover, MeOH25 subfraction showed signals in the aliphatic (2.1-2.3 ppm), anomeric (3.6, 4.1 ppm), and aromatic (5.6, 6.3, 6.8-7.1, and 7.6 ppm) regions (already seen in Figure 4C). The latter group of signals may be assigned to dicaffeoyl moiety. Following 13C- and 2D NMR experiments on this fraction, we identified unequivocally 3,5 dicaffeoylquinic acid as the major compound (Figure 6B, and supplementary data).
The MeOH60 fraction showed several signals in the 6-8 ppm region, corresponding to aromatic compounds (Figure 4D). Some of them are likely glycosylated, as revealed by the signals in the ose and anomeric protons regions.
The NMR spectrum of MeOH80 fraction showed numerous signals between 5.6 and 8 ppm, and pronounced ones between 1 and 2 ppm, corresponding to aromatic and aliphatic protons, respectively (Figure 4E). Further fractioning of this fraction allowed us to isolate a pure compound eluted with 65% MeOH. This compound was characterized by signals at 1.9, 5.7, 6.1, 6.3, and 7.9 ppm on 1H-NMR spectrum, and 2D-NMR (COSY, HMQC, and HMBC) experiments allowed us to identify this compound as 5-(4-hexen-2-ynylidene) furan-2-one, also known as matricaria lactone (Figure 6C).
The last two fractions, eluted with MeOH100 and ethyl acetate, contained apolar compounds showing aliphatic protons and minor signals in the 1-2 ppm and 6-7 ppm regions, respectively (Figures 4F,G).
Figure 5. 1D- and 2D-NMR data of tripleurospermine isolated from the MeOH40 fraction of T. maritimum. 2D-NMR spectra of MeOH20 subfraction of the MeOH40 fraction of T. maritimum leaf extract, showing spin systems of tripleurospermine in COSY (A), HMQC (B) and HMBC (C) experiments.
Figure 5. 1D- and 2D-NMR data of tripleurospermine isolated from the MeOH40 fraction of T. maritimum. 2D-NMR spectra of MeOH20 subfraction of the MeOH40 fraction of T. maritimum leaf extract, showing spin systems of tripleurospermine in COSY (A), HMQC (B) and HMBC (C) experiments.
Preprints 151386 g005
Figure 6. Chemical structures of compounds isolated from T. maritimum fractions: 3,5-dicaffeoylquinic acid (A), tripleurospermine (B), and matricaria lactone (C).
Figure 6. Chemical structures of compounds isolated from T. maritimum fractions: 3,5-dicaffeoylquinic acid (A), tripleurospermine (B), and matricaria lactone (C).
Preprints 151386 g006

3. Discussion

Over the past decades, the search for natural products in plants has led to the discovery of a number of biologically active substances, particularly secondary metabolites. Among those, phenolic compounds are widely represented in most medicinal or halophytic species and exhibit a number of biological activities [24]. Whereas the chemical composition and biological properties of extracts from Aster or Matricaria genera are highly documented [10,15,19,25], research on Tripleurospermum is scarce [26]. In particular, the chemical composition and biological activities of the edible halophyte sea mayweed (T. maritimum) has received little attention so far. Here, we describe the purification of hydroalcoholic leaf extract and the identification of its major compounds, along with some relevant biological properties.
Solid-liquid partition chromatography of the extract on C18-bound silica gel allowed us to purify some major compounds in sea mayweed leaves. The MeOH20 fraction appeared to be composed mainly of an oligofructan, α-D-Glcp-(1→2)-[β-D-Fruf-(2→1)-β-D-Frucf]n-(2→1)-β-D-Fruf, already described in M. maritima raw extract [23]. The mechanical properties of this fructo-oligosaccharide may have promising pharmacological applications or be used for reinforcement of polymer matrix composites [27]. Here, this fraction exhibited a mild anti-oxidant capacity, probably related to its phenolic content. However, this fraction did not show any other biological activity with the bioassays used here.
Particular attention was given to the MeOH40 fraction, where 1D and 2D NMR experiments led to the identification of 3-5-dicaffeoylquinic acid and a never reported carbohydrate, namely tripleurospermine, as major compounds. Interestingly, this fraction exhibited the highest phenolic content and the strongest antioxidant activities (with FRAP and ABTS bioassays). Phenolic compounds are well known to have a number of biological properties, including antioxidant activity [28]. Consequently, halophytes, which are rich in phenolics, have been reported to have a strong antioxidant potential [24,29,30]. Among phenolic compounds, caffeoyl derivatives are known to contribute significantly to the antioxidant activity of plants such as Asteraceae [25]. These authors reported the presence of 3,5-dicaffeoylquinic acid in several members of this family, including a species closely related to sea mayweed, Matricaria perforata. The antioxidant capacity of the two compounds purified in MeOH40 fraction has been tested. Interestingly, our results showed for the first time that the newly isolated molecule tripleurospermine exerts a significant activity, though lower than that of the caffeoyl derivative. Noteworthy, this MeOH40 fraction also exhibited a marked capacity to inhibit tyrosinase activity, a well-known oxidizing enzyme responsible for melanin formation in the skin. The activity level, reported here for the first time in this species, was close to that of the standard tyrosinase inhibitor kojic acid. Moreover, it appears higher than that recently reported in other halophytic species like Crithmum maritimum (Magné, unpublished data), Citrullus colocynthis, Daemia cordata, Inula crithmoides or Plantago coronopus [31,32]. Such observation were further confirmed by a strong tyrosinase inhibitory action of purified tripleurospermine (315 ± 44 mg KAE/gDW), and to a lesser extent of 3,5-dicaffeoylquinic acid (294 ± 28 mg KAE/gDW). Therefore, the oxidative enzyme tyrosinase is likely inhibited in the MeOH40 fractions by its major antioxidant phenolic compound, which is in accordance with the review of Chang [33]. This result confirms that a positive correlation could be made between antioxidant and anti-tyrosinase activities, as reported previously by Choi et al. [34]. However, this fraction exhibited no activities against melanogenesis or other ageing-related enzymes like elastase and collagenase, confirming a previous observation made in a closely-related species, Matricaria recutita [35]. Besides, the MeOH40 fraction exhibited a marked capacity to inhibit α-glucosidase activity, a well-known hypoglycemic enzyme involved in carbohydrate digestion. This observation is in agreement with recent work by Spínola and Castilho [36], showing a strong hypoglycemic effect of caffeoylquinic acids from Asteraceae plants. Therefore, this fraction could be used as an adjuvant to prevent Type 2 diabetes.
The MeOH60 fraction showed the widest range of biological activities, as seen by its strong antioxidant, anti-tyrosinase, anti-inflammatory, neuroprotective, and anti-diabetic capacities. Noteworthy was its strong capacity to inhibit NO production and α-glucosidase, making this fraction a potential source of bioactive drugs, particularly against inflammation or diabetes syndromes. Since the MeOH60 fraction has a high level and diversity of phenolic compounds, it could be that these compounds are responsible for its wide range of activities. Accordingly, anti-inflammatory [37] and antidiabetic [36,38] properties of phenolics have been reported in other Asteraceae. Besides, phenolics have been shown to inhibit tyrosinase [39] and ameliorate neurodegenerative process [40]. Further investigation aimed at purifying major compounds in this fraction is needed to ascribe the action of the different compounds in this fraction.
The MeOH80 fraction exhibited a strong antioxidant capacity. Following sub-fractioning, a major compound was identified, namely 2(5H)-furanone, 5-(4-hexen-2-yn-1-ylidene), also known as matricaria lactone. Matricaria lactone has been previously identified in other members of Asteraceae, including Conyza (= Erygeron) or Matricaria genera [14,41], where it was reported to exert antifungal properties [41,42]. Since this lactone appeared as the major compound in the MeOH80 fraction, it likely explains its strong antioxidant and anti-tyrosinase properties. However, to the best of our knowledge, neither antioxidant nor anti-tyrosinase activity had been reported before for this compound. Besides, this fraction also showed a strong anti-inflammatory capacity (3-fold higher than the standard L-NAME). Since terpene lactones have been reported to have anti-inflammatory effects [37], it could be that the NO inhibitory effect of MeOH80 fraction is due to matricaria lactone. Besides, this fraction strongly inhibited α-glucosidase. A potential antidiabetic action of lactones has not been reported hitherto, and further work is needed to assess the potential effect of pure matricaria lactone on this enzyme.
The last two fractions, eluted with MeOH100 and ethyl acetate, exhibited mainly apolar compounds, as evidenced by their NMR analysis showing major signals of aliphatic protons. These signals suggest the presence of terpenoids and/or steroids as major constituents in these fractions since such chemicals are commonly found in Asteraceae [43,44,45]. Interestingly, steroids and terpenoids have been reported to inhibit tyrosinase [46,47,48], and the last two fractions of sea fennel extract exhibited the most powerful anti-tyrosinase activity, being as active as the whitening standard agent (kojic acid) used in the cosmetic industry. However, these fractions had low antioxidant activities, though tyrosinase catalyzes two oxidative reactions. Hence, the contribution of non-antioxidant mechanisms to tyrosinase inhibition could not be excluded. Moreover, the last fraction of sea mayweed extract was the only one to exhibit anti-melanogenesis properties and showed a remarkable α-glucosidase inhibitory action. These activities could be related to some low-polar constituents like terpenoids, as reported by Kanlayavattanakul and Lourith51 and Patel et al. [49], respectively. Besides, no other anti-aging activities (e.g,. anti-elastase or anti-collagenase activities) were observed in sea mayweed raw extract or fractions at the tested concentrations. Our results confirm those reported in a T. maritima related species, Matricaria recutita, where neither anti-elastase nor anti-collagenase activity could be found [35].

4. Materials and Methods

4.1. Chemicals, Culture Media and Supplements

Lipase (EC 3.1.1.3), acetylcholinesterase (EC 3.1.1.7), α-glucosidase (EC 3.2.1.20), α-amylase (EC 3.2.1.1), tyrosinase (EC 1.14.18.1), and B16 A45 murine melanoma cell line were purchased from Sigma-Aldrich (Germany). Folin-Ciocalteau phenol reagent, all standards and solvents used for chemical analyses were supplied by Sigma Aldrich (St. Louis, MO, USA).

4.2. Plant Material

Seeds of T. maritimum were collected on a sand beach at Le Conquet (48°21’37” North, 4°46’15” West, France). Seeds were disinfected with a saturated solution of calcium hypochlorite (30%) for 3 min, and rinsed in distilled water. They were germinated for 10 days at 20°C in Petri dishes on filter paper moistened with 0.1 mM CaSO4. Then, germinated seeds were transferred in 250 mL pots filled with a mixture of sand and sterile loam (1:1 v/v), and watered daily with Hewitt nutrient solution [50]. Seedlings were grown in a greenhouse under controlled conditions: 14-23°C and 50-70% relative humidity, 8-16 h night-day photoperiod. The aerial parts of 3 month-old T. maritimum plants were harvested, immediately frozen, and freeze-dried. Dried samples were then powdered and stored at room temperature until extraction.

4.3. Extraction and Fractionation

About 1 g of leaf powder was homogenized with 25 mL of water/ethanol (1:2) under magnetic stirring at 4°C for 20 min. After centrifugation of the mixture (15 min at 4°C, 4.000 × g), the resulting pellet was extracted twice following the same protocol. The supernatants were collected, pooled, and filtrated over glass wool. The obtained extract was concentrated by rotary evaporation at 40°C and resuspended in 50% ethanol.
Fractionation of the raw extract (approx. 0.3 g) was performed by solid-liquid partition chromatography on C18-bound silica gel (GRACE Davisil RP18). The elution of polar compounds proceeded by increasing methanol concentration in water (successively 0, 20, 40, 60, 80, 100%) and finally ethyl acetate. The fractions were then concentrated by rotary evaporation at 30°C and resuspended in the corresponding solvent. Further fractionation of MeOH40 fraction was performed on the same column, using the same method but with smaller MeOH increments (i.e. MeOH 20%, 25%, 30%, 35%, and 40%). When necessary, a subfraction was submitted to acid hydrolysis treatment (1 N HCl, 110°C for 1 h) before structural elucidation.

4.4. Antioxidant Activities

4.4.1. DPPH Scavenging Activity

The scavenging activity of the stable 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical was determined by the method of Marwah et al. [51]. Briefly, the reaction medium contained 100 μL of 100 μM DPPH· solution in ethanol and 100 μL of plant extract at different concentrations (or water for the control). The reaction mixture was incubated in the dark for 15 min and the absorbance was recorded at 517 nm with a Multiskan FC microplate reader (Thermo Scientific Technologies, China). The assay was carried out in triplicate. The decrease in absorbance upon addition of test samples was used to calculate the inhibition percentage (%IP) of DPPH radical, following the equation:
%IP = [(Ac−As) / Ac] × 100
where Ac and As are the absorbances of the control and the test sample, respectively. From a plot of concentration against %IP, a linear regression analysis was performed to determine the antiradical activity, as expressed by the IC50 (extract concentration resulting in a 50% inhibition) value for each sample.

4.4.2. Ferric Reducing Activity (FRAP)

The assay is based on the reaction of Fe2+ with 2,4,6-tri(pyridyl)-s-triazine (TPTZ) to form a violet-blue color with maximal absorbance at 593 nm [52,53]. The FRAP solution was prepared by mixing 10 volumes of acetate buffer (300 mM, pH 3.6) with 1 volume of TPTZ (40 mM in HCl) and 1 volume of ferric chloride (20 mM in water). The solution was prepared daily and warmed at 37°C for 10 minutes before use. A 280 μL aliquot of this solution was mixed with 20 μL of samples (extract, fractions, or water for the blank) in a 96-well microplate. The mixture was incubated at 37°C in the dark for 30 minutes and then read at 593 nm. The increase in absorbance upon addition of test samples was used to calculate the reducing capacity, as expressed by the efficacy percentage (%EP):
%EP = [(As−Ac) / Ac] × 100
where As and Ac are the absorbances of the control and the test sample, respectively. From a plot of concentration against %EP, a linear regression analysis was performed to determine the EC50 (extract concentration resulting in 50% efficacy) value for each sample.

4.4.3. ABTS Scavenging Activity

The ABTS radical scavenging assay was based on the method described by Re et al. [54] with a slight modification. Briefly, a 7 mM ABTS stock solution was prepared by dissolving ABTS in ethanol:water (5:1 v/v). Then, an aliquot of this solution was reacted with 2.45 mM potassium persulfate in ethanol:water (1:3 v/v) and allowed to stand in dark at room temperature for 16-20 h to prepare the ABTS radical cation (ABTS·+). This ABTS radical solution was diluted to an absorbance at 734 nm of 0.70 ± 0.02. Finally, the absorbance of a mixture consisting of sample (or water for the blank) and ABTS reagent was measured at 734 nm. The antiradical capacity of the samples was expressed as Trolox equivalents (mg TE.g DW-1).

4.5. Anti-Ageing Activity

Anti-tyrosinase assay was performed using L-DOPA as substrate, according to the method described by Masuda et al. [55]. The samples (plant extract or fractions) were dissolved in 50% dimethyl sulfoxide (DMSO). Then, 40 μL of each sample were mixed with 80 μL of phosphate buffer (0.1 M, pH 6.8), 40 μL of tyrosinase (31 units.mL-1 in phosphate buffer, pH 6.5) and 40 μL of 2.5 mM L-DOPA in a 96-well microplate. The absorbance of the mixture was measured at 475 nm and compared to that of a positive control containing kojic acid and a blank containing all the components except L-DOPA. The anti-tyrosinase activity was expressed as kojic acid equivalents (mg KAE.g DW-1).
Anti-elastase activity was assayed according to the method described by Kim et al. [56], slightly modified to perform the assay in 96-well microplates. The substrate N-Succinyl-Ala-Ala- Ala-p-nitroanilide (SANA) was dissolved in Tris-HCL buffer (0.2 M, pH 8.0) at 1.6 mM. Plant extract or fractions were incubated with porcine pancreatic elastase (E.C. 3.4.21.36) at 10 μg.mL-1 for 20 minutes at 37°C before adding substrate. Epigallocatechin gallate (EGCG) was used as a positive control. Absorbance at 410 nm was measured 20 minutes after substrate addition. The percentage of enzyme inhibition was calculated as follows:
Enzyme inhibition (%) = [(Acontrol − Asample) / Acontrol] × 100
Anti-collagenase activity was assayed using the ENZO MMP-1 kit (Colorimetric Drug Discovery Kit), adapted to 96-well microplates. The assay was performed in 50 mM HEPES buffer (pH 7.5) containing 0.05% Brij-35, 1 mM DTNB and 10 mM CaCl2. MMP-1 (Matrix MetalloProteinase-1) was dissolved in this buffer at an initial concentration of 0.76 units.mL-1. The synthetic substrate (chromogenic peptidic substrate) was dissolved in HEPES buffer to 1 mM. Plant extracts were incubated with the enzyme in buffer for 15 minutes before adding the substrate. The specific inhibitor [N-Isobutyl-N-(4-methoxyphenylsulfonyl) glycyl hydroxamic acid] was used as a positive control. Absorbance at 412 nm was measured every minute from 10 to 20 min after substrate addition. The percentage of enzyme inhibition was calculated as follows:
Enzyme inhibition (%) = (Vsample / Vcontrol) × 100
where Vsample and Vcontrol are the linear regression slopes of the inhibition due to sample and control, respectively.
Moreover, the anti-melanogenic activity of sea mayweed extract and fractions was assessed in vitro on B16 4A5 melanoma cells according to Bouzaiene et al. [57]. Cells were seeded at 3.5×104 cells/well into 12-well plates, allowed to adhere for 24 h, and then treated with sea mayweed extract concentrations that allowed cellular viability higher than 80% for 72 h. Thereafter, adherent cells were trypsinized and solubilized in 1 mL of 1% sodium dodecyl sulfate (SDS). The absorbance of the samples was measured at 475 nm, and the melanin content was estimated using a standard curve of synthetic melanin (0–25 μg.mL-1).

4.6. Neuroprotective Activity

The neuroprotective property of sea mayweed extract was evaluated through the in vitro inhibition of acetylcholinesterase (AChE) according to Custódio et al. [58]. Samples (20 µL at concentrations of 1, 5, and 10 mg.mL-1) were mixed with 140 µL of sodium phosphate buffer (0.1 mM, pH 8.0) and 20 µL of AChE solution (0.28 U.mL-1) in 96-well microplates. The mixture was incubated for 15 min at room temperature, and the reaction was initiated by the addition of 10 µL of 4 mg.mL-1 ATChI and 20 µL of 1.2 mg.mL-1 DTNB. The absorbance was read at 405 nm and results were expressed as IC50 relative to a control containing water instead of extract. Galantamine was used as a positive control.

4.7. Anti-Diabetic Activity

Sea mayweed extract and fractions, at concentrations ranging from 1 to 5 mg.mL-1, were evaluated for their capacity to inhibit α-amylase and α-glucosidase according to Zengin [59]. Moreover, extract and fractions were tested against porcine lipase according to McDougall et al. [60]. Acarbose was used as a positive control for α-amylase and α-glucosidase, and orlistat was used as a positive control for lipase inhibition. Results were expressed as IC50 relative to a control containing DMSO.

4.8. Anti-Inflammatory Activity

Nitric oxide (NO) production by LPS-stimulated RAW 264.7 macrophages was assessed as described by Rodrigues et al. [61]. RAW 264.7 cells were cultured in RPMI 1640 culture medium, enriched with 10% heat-inactivated FBS, 1% L-glutamine (2 mM), and 1% penicillin (50 U.mL-1) / streptomycin (50 μg.mL-1), and kept at 37ºC in a 5% CO2 humidified atmosphere. Murine cells were seeded in a 96-well plate at 2.5 x 105 cells per well and allowed to adhere overnight. Then, they were co-treated with 100 ng.mL-1 of LPS and sea mayweed raw extract (at concentrations that allowed cellular viability higher than 80%) for 24 h. NO production was assessed using the Griess assay. Results were expressed as a percentage of inhibition of NO production, relative to a control containing DMSO (0.5%, v/v), and compared to the positive control L-nitroarginine methyl ester (L-NAME).

4.9. NMR Analyses

Dry fractions were dissolved in 700 μL of 99.5% D2O and placed in 5 mm NMR tubes. 1H and 13C NMR spectra were obtained at 298°K on a Bruker DRX-400 spectrometer (400 MHz), equipped with a 5 mm dual 1H/13C probe head, using standard pulse sequences available in the Bruker Software (Bruker, Wissembourg, France). A typical 1D 1H NMR spectrum consisted of 32 scans, and 2,2,3,3-tetradeuterio-3-(trimethylsilyl)-propanoic acid sodium salt was used as an internal standard. For 13C (J-mod) and 2D 1H NMR (COSY, HMBC, HMQC, TOCSY) analyses, experiments were carried out at 298°K on a Bruker Avance III HD500 spectrometer equipped with an inverse 5 mm TCI cryoprobe with z gradient. Data were processed using TopSpin® 4.0 software (Bruker).

4.10. Mass Spectrometry Analysis

When needed, characterization of a purified compound was performed on an Autoflex (Bruker, France) ion trap mass spectrometer equipped with a Matrix-Assisted Laser Desorption/Ionization (MALDI) source and a quadrupole time-of flight (QTOF) analyzer. Spectra were acquired in negative-ion mode over a mass range from m/z 100 to 1500 with 5 Hz frequency. Operating parameters of the MALDI ion source were as follows: capillary voltage 3 kV, dry gas flow 6 L.min-1, dry gas temperature 200°C, nebulizer pressure 0.7 bar, collision radio frequency 700.0 V, transfer time 100.0 μs, and pre-pulse storage 7.0 μs. Ultrapure nitrogen was used as drying and nebulizer gas, and argon was used as collision gas. Collision energy was set automatically from 15 to 75 eV depending on the m/z of fragmented ion. Acquired data were calibrated internally with sodium formate introduced to the ion source at the beginning and ending of each separation via a 20 μL loop. Control and data acquisition were carried out with the Bruker DataAnalysis 4.3 software.

4.11. Statistical Analyses

All extractions and assays were conducted in triplicate. Results were expressed as mean ± standard deviation (SD), and the means were compared by using one-way analysis of variance (ANOVA) followed by Duncan’s multiple range tests performed by the ‘‘Statistica v. 5.1’’ software (Statsoft, 2008). Differences between individual means were deemed to be significant at P < 0.05. The IC50 values were calculated by the sigmoidal fitting of the data using the GraphPad Prism v. 5.0 program.

5. Conclusions

Biological activities and chemical composition of T. maritimum were thoroughly investigated here for the first time. Solid-liquid partition chromatography of the crude extract and NMR characterization of its fractions allowed us to purify major compounds, including fructo-oligosaccharides in the MeOH20 fraction, a new carbohydrate (tripleurospermine, 1) and 3-5-dicaffeoylquinic acid (2) in MeOH40 fraction, and matricaria lactone (3) in the MeOH80 fraction. Both (1) and (2) compounds exhibited strong antioxidant and anti-tyrosinase activities, but no other anti-ageing properties. The MeOH60 fraction appeared as the most active fraction, with antioxidant, anti-inflammatory, neuroprotective, and anti-diabetic properties. The less polar fractions were particularly active against tyrosinase. Overall, this work shows that sea mayweed should find dietary or medicinal uses, as an interesting source of prebiotics (FOS) and of phyto-pharmaceutical preparations for inflammation or diabetes control.

Supplementary Materials

NMR spectroscopic data (500 MHz, CDCl3) for 3,5-di-O-caffeoylquinic acid identified in the MeOH40 fraction of sea mayweed extract.

Acknowledgments

The authors acknowledge ANRT for funding the Ph.D. work of C. Lemoine (convention No. 2014/1093). The Portuguese team acknowledges Foundation for Science and Technology (FCT) and the Portuguese National Budget (CCMAR/Multi/04326/2019 project). Luísa Custódio was supported by the FCT Investigator Programme (CEECIND/00425/2017).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Abbreviations

ABTS, 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid); L-DOPA, L-dihydroxyphenylalanine; DPPH, 2,2-diphenyl-1-picrylhydrazyl; DTNB, 5,5′-dithiobis-(2-nitrobenzoic acid); EGCG, Epigallocatechin gallate; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; HMBC, heteronuclear multiple bond coherence; HMQC, heteronuclear multiple quantum coherence; MALDI, Matrix-Assisted Laser Desorption/Ionization; MeOD, deuterated methanol; MeOH, methanol; NMR, nuclear magnetic resonance.

References

  1. Applequist, W.L. A Reassessment of the Nomenclature of Matricaria L. and Tripleurospermum Sch. Bip. (Asteraceae). Taxon 2002, 51(4), 757. [CrossRef]
  2. Oberprieler, C.; Himmelreich, S.; Vogt, R. A new subtribal classification of the tribe Anthemideae (Compositae). Willdenowia 2007, 37, 89–114. [CrossRef]
  3. Kim, S.; Jung, E.; Kim, J.H.; Park, Y.H.; Lee, J.; Park, D. Inhibitory effects of (-)-α-bisabolol on LPS-induced inflammatory response in RAW264.7 macrophages. Food Chem. Toxicol. 2011, 49, 2580-2585.
  4. Bulgari, M.; Sangiovanni, E.; Colombo, E.; Maschi, O.; Caruso, D.; Bosisio, E.; Dell’Agli, M. Inhibition of Neutrophil Elastase and Metalloprotease-9 of Human Adenocarcinoma Gastric Cells by Chamomile (Matricaria recutita L.) Infusion. Phytother. Res. 2012, 26, 1817-1822. [CrossRef]
  5. Ranpariya, V.L.; Parmar, S.K.; Sheth, N.R.; Chandrashekhar, V.M. Neuroprotective activity of Matricaria recutita against fluoride-induced stress in rats. Pharm. Biol. 2011, 49(7), 696-701. [CrossRef]
  6. Chandrashekhar, V.M.; Halagali, K.S.; Nidavani, R.B.; Shalavadi, M.H.; Biradar, B.S.; Biswas, D.; Muchchandi, I.S. Anti-allergic activity of German chamomile (Matricaria recutita L.) in mast cell mediated allergy model. J. Ethnopharmacol. 2011, 137, 336-340. [CrossRef]
  7. Silva, N.; Barbosa, L.; Seito, L.; Fernandes Junior, A. Antimicrobial activity and phytochemical analysis of crude extracts and essential oils from medicinal plants. Nat. Prod. Res. 2012, 26, 1510-1514. [CrossRef]
  8. Sharifi-Rad, M.; Nazaruk, J.; Polito, L.; Bezerra Morais-Braga, M.F.; Rocha, J.E.; Melo Coutinho, H.D.; Salehi, B.; Tabanelli, G.; Montanari, C.; del Mar Contreras, M.; Yousaf, Z.,; Setzer, W.N.; Verma, D.R.; Martorell, M.; Sureda, A.; Sharifi-Rad, J. Matricaria genus as a source of antimicrobial agents: From farm to pharmacy and food applications. Microbiol. Res. 2018, 215, 76-88. [CrossRef]
  9. Matić, I.Z.; Juranić, Z.; Savikin, K.; Zdunić, G.; Nađvinski, N.; Gođevac, D. Chamomile and marigold tea: chemical characterization and evaluation of anticancer activity. Phytother. Res. 2013, 27(6), 852-858. [CrossRef]
  10. Sebai, H.; Jabri, M.A.; Souli, A.; Rtibi, K.; Selmi, S.; Tebourbi, O.; El-Benna, J.; Sakly, M. Antidiarrheal and antioxidant activities of chamomile (Matricaria recutita L.) decoction extract in rats. J. Ethnopharmacol. 2014, 152(2), 327-32. [CrossRef]
  11. Zekovic, Z.; Pekic, B.; Lepojevic Z.; Petrovic L. Study of the extraction of chamomile flowers with supercritical carbon dioxide. Chromatographia 1994, 39, 587-590.
  12. Öztürk, E.; Ozer, H.; Cakir, A.; Mete, E.; Kandemir, A.; Polat, T. Chemical Composition of the Essential Oil of Tripleurospermum corymbosum E. Hossain, an Endemic Species from Turkey. J. Essent. Oil Bear. Pl. 2013, 13, 148-153. [CrossRef]
  13. Mulinacci, N.; Romani, A.; Pinelli, P.; Vincieri, F.; Prucher, D. Characterization of Matricaria recutita L-flower extracts by HPLC-MS and HPLC-DAD analysis. Chromatographia 2000, 51(5), 301-307. [CrossRef]
  14. Raal, A.; Püssa, T.; Sepp, J.; Malmiste, B.; Arak, E. Content of phenolic compounds in aerial parts of Chamomilla suaveolens from Estonia. Nat. Prod. Commun. 2011, 6(8), 1107-1110. [CrossRef]
  15. Xie, X.Y.; Wang, R.; Shi, Y.P. Flavonoids from the Flowers of Matricaria chamomilla. Chem. Nat. Compd., 50, 910-911. [CrossRef]
  16. Kovacik, J.; Repcak, M. Accumulation of coumarin-related compounds in leaves of Matricaria chamomilla related to sample processing. Food Chem. 2008, 111 (3), 755-757. [CrossRef]
  17. Kovalikova Ducaiova, Z.; Sajko, M.; Mihaličová, S.; Repčák, M. Dynamics of accumulation of coumarin-related compounds in leaves of Matricaria chamomilla after methyl jasmonate elicitation. Plant Growth Regul. 2015, 79, 81-94. [CrossRef]
  18. Petronilho, S.; Maraschin, M.; Coimbra, M.A.; Rocha, S.M. In vitro and in vivo studies of natural products: A challenge for their valuation. The case study of chamomile (Matricaria recutita L.). Indus. Crops Prod. 2012, 40, 1–12. [CrossRef]
  19. Singh, O.; Khanam, Z.; Misra, N.; Srivastava M.K. Chamomile (Matricaria chamomilla L.): An overview. Pharmacogn. Rev. 2011, 5(9), 82-95.
  20. Parvini, S.; Hosseini, M.J.; Bakhtiarian, A. The Study of Analgesic Effects and Acute Toxicity of Tripleurospermum disciforme in Rats by Formalin Test. Toxicol. Mech. Method. 2007, 17(9), 575-580. [CrossRef]
  21. Tofighi, Z.; Molazem, M.; Doostdar, B.; Taban, P.; Shahverdi, A.R.; Samadi, N.; Yassa, N. Antimicrobial Activities of Three Medicinal Plants and Investigation of Flavonoids of Tripleurospermum disciforme. Iran J. Pharm. Res. 2015, 14(1), 225-31.
  22. Al-Saleem, M.S.; Awaad, A.S.; Alothman, M.R.; Alqasoumi, S.I. Phytochemical standardization and biological activities of certain desert plants growing in Saudi Arabia. Saudi Pharm. J. 2018, 26(2), 198-204. [CrossRef]
  23. Cérantola, S.; Kervarec, N.; Pichon, R.; Magné, C.; Bessières, M.A.; Deslandes, E. NMR characterisation of inulin-type fructooligosaccharides as the major water-soluble carbohydrates from Matricaria maritima L. Carbohydr. Res. 2004, 339, 2445-2449. [CrossRef]
  24. Ksouri, R.; Megdiche, W.; Jallali, I.; Debez, H.; Magné, C.; Isoda, H.; Abdelly, C. Medicinal halophytes: potent source of health promoting biomolecules with medical, nutraceutical and food applications. Crit. Rev. Biotechnol. 2012, 32 (4), 289-326.
  25. Fraisse, D.; Felgines, C.; Texier, O.; Lamaison, J. Caffeoyl Derivatives: Major Antioxidant Compounds of Some Wild Herbs of the Asteraceae Family. Food Nutr. Sci. 2011, 2(3), 181-192. [CrossRef]
  26. Ćavar Zeljković, S.; Ayaz, F.A.; Inceer, H.; Hayirlioglu-Ayaz, S.; Colak, N. Evaluation of chemical profile and antioxidant activity of Tripleurospermum insularum, a new species from Turkey. Nat. Prod. Res. 2015, 29(3), 293-296. [CrossRef]
  27. Davies, P.; Bourmaud, A.; Pajot, A.; Baley, C.A preliminary evaluation of Matricaria maritimum fibres for polymer reinforcement. Indus. Crops Prod. 2011, 34, 1652-1654. [CrossRef]
  28. Rice-Evans, C.A.; Miller, N.J.; Paganga, G. Structure–antioxidant activity relationships of flavonoids and phenolic acids. Free Rad. Biol. Med. 1996, 20, 933-956. [CrossRef]
  29. Méot-Duros, L.; Magné, C. Antioxidant activity and phenol content of Crithmum maritimum (L.) leaves. Plant Physiol. Bioch. 2009, 47(1), 37-41. [CrossRef]
  30. Falleh, H.; Oueslati, S.; Guyot, S.; Ben Dali, A.; Magné, C.; Abdelly, C.; Ksouri, R. LC/ESI-MS/MS characterisation of procyanidins and propelargonidins responsible for the strong antioxidant activity of the edible halophyte Mesembryanthemum edule L. Food Chem. 2011, 127(4), 1732-1738. [CrossRef]
  31. Jdey, A.; Falleh, H.; Ben Jannet, S.; Mkadmini Hammi, K.; Dauvergne, X.; Ksouri, R.; Magné, C. Phytochemical investigation and antioxidant, antibacterial and anti-tyrosinase performances of six medicinal halophytes. S. Afr. J. Bot. 2017a, 112, 508-514. [CrossRef]
  32. Jdey, A.; Falleh, H.; Ben Jannet, S.; Hammi, K.M.; Dauvergne, X.; Magné, C.; Ksouri, R. Anti-aging activities of extracts from Tunisian medicinal halophytes and their aromatic constituents. EXCLI J. 2017b, 16, 755-769. [CrossRef]
  33. Chang, T.S. An updated review of tyrosinase inhibitors. Int. J. Mol. Sci. 2009, 10, 2440–2475. [CrossRef]
  34. Choi, H.K.; Lim, Y.S.; Kim, Y.S.; Park, S.Y.; Lee, C.H.; Hwang, K.W. Free-radical-scavenging and tyrosinase-inhibition activities of Cheonggukjang samples fermented for various times. Food Chem. 2008, 106, 564–568. [CrossRef]
  35. Thring, T.S.; Hili, P.; Naughton, D.P. Anti-collagenase, anti-elastase and anti-oxidant activities of extracts from 21 plants. BMC Complement. Altern. Med. 2009, 9, 27. [CrossRef]
  36. Song, J.L.; Song, R.K.; Gao, Y.Y. Anti-inflammatory effect of methanolic extract of Conyza canadensis in lipopolysaccharide (LPS)-stimulated RAW264.7 murine macrophage cells. Pak. J. Pharm. Sci. 2016, 29(3), 935-940.
  37. Spínola, V.; Castilho, P.C. Evaluation of Asteraceae herbal extracts in the management of diabetes and obesity. Contribution of caffeoylquinic acids on the inhibition of digestive enzymes activity and formation of advanced glycation end-products (in vitro). Phytochemistry 2017, 143, 29-35. [CrossRef]
  38. Idres, A.Y.; Tousch, D.; Dhuyque-Mayer, C.; Hammad, I.; Lambert, K.; Cazals, G.; Portet, K.; Ferrare, K.; Bidel, L.P.R.; Poucheret, P. An Original Asteraceae Based Infused Drink Prevents Metabolic Syndrome in Fructose-Rat Model. Antioxidants (Basel) 2023, 12(2), 340. [CrossRef]
  39. Kanlayavattanakul, M.; Lourith, N. Plants and natural products for the treatment of skin pigmentation – A review. Planta Med. 2018, 84(14), 988-1006. [CrossRef]
  40. Shahidi, F.; Yeo, J.D. Bioactivities of Phenolics by Focusing on Suppression of Chronic Diseases: A Review. Int. J. Mol. Sci. 2018, 19(6), 1573-1589. [CrossRef]
  41. Vidari, G.; Abdo, S.; Gilardoni, G.; Ciapessoni, A.; Gusmeroli, M.; Zanoni, G. Fungitoxic metabolites from Erigeron apiculatus. Fitoterapia 2006, 77(4), 318-320. [CrossRef]
  42. Queiroz, S.C.; Cantrell, C.L.; Duke, S.O.; Wedge, D.E.; Nandula, V.K.; Moraes, R.M.; Cerdeira, A.L. Bioassay-directed isolation and identification of phytotoxic and fungitoxic acetylenes from Conyza canadensis. J. Agric. Food Chem. 2012, 60(23), 5893-5898. [CrossRef]
  43. Ekundayo, O.; Laasko, I.; Hiltunen, R. Essential oil of Ageratum conyzoides. Planta Med. 1988, 54, 55-57.
  44. Wiedenfeld, H.; Roder, E. Pyrrolizidine Alkaloids from Ageratum conyzoides. Planta Med. 1991, 57, 578-579. [CrossRef]
  45. Okunade, A.L. Ageratum conyzoides L. (Asteraceae). Fitoterapia 2002, 73, 1-16.
  46. Magid, A.A.; Voutquenne-Nazabadioko, L.; Bontemps, G.; Litaudon, M.; Lavaud, C. Tyrosinase inhibitors and sesquiterpene diglycosides from Guioa villosa. Planta Med. 2008, 74, 55-60. [CrossRef]
  47. Lee, S.Y.; Baek, N.; Nam, T.G. Natural, semisynthetic and synthetic tyrosinase inhibitors. J. Enzyme Inhib. Med. Chem. 2016, 31, 1-13. [CrossRef]
  48. Stefanis, I.; Hadjipavlou-Litina, D.; Bilia, A.R.; Karioti, A. LC-MS- and NMR-guided isolation of monoterpene dimers from cultivated Thymus vulgaris Varico 3 hybrid and their antityrosinase activity. Planta Med. 2019, 85, 941-946. [CrossRef]
  49. Patel, D.K.; Prasad, S.K.; Kumar, R.; Hemalatha, S. An overview on antidiabetic medicinal plants having insulin mimetic property. Asian Pac. J. Trop. Biomed. 2012, 2(4), 320-330. [CrossRef]
  50. Hewitt, E.J. Sand and Water Culture Methods Used in the Study of Plant Nutrition. Technical Communication No. 22. Commonwealth Bureau, London. 2nd ed., 1966.
  51. Marwah, R.G.; Fatope, M.O.; Mahrooqi, R.A.; Varma, G.B.; Abadi, H.A.; Al-Burtamani, S.K.S. Antioxidant capacity of some edible and wound healing plants in Oman. Food Chem. 2007, 101, 465–470.
  52. Jimenez-Alvarez, D.; Giuffrida, F.; Vanrobaeys, F.; Golay, P.A.; Cotting, C.; Lardeau, A.; Keely, B.J. High-throughput methods to assess lipophilic and hydrophilic antioxidant capacity of food extracts in vitro. J. Agric. Food Chem. 2008, 56, 3470–3477. [CrossRef]
  53. Bolanos de la Torre, A.A.S.; Henderson, T.; Nigam, P.S.; Owusu-Apenten, R.K. A universally calibrated microplate ferric reducing antioxidant power (FRAP) assay for foods and applications to Manuka honey. Food Chem. 2015, 174, 119–123. [CrossRef]
  54. Re, R.; Pellegrini, N.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Rad. Biol. Med. 1999, 26, 1231–1237. [CrossRef]
  55. Masuda, T.; Yamashita, D.; Takeda, Y.; Yonemori, S. Screening for tyrosinase inhibitors among extracts of seashore plants and identification of potent inhibitors from Garcinia subelliptica. Biosci. Biotechnol. Biochem. 2005, 69, 197-201. [CrossRef]
  56. Kim, Y.; Uyama, H.; Kobayashi, S. Inhibition effects of (+)-catechinaldehyd polycondensates on proteinases causing proteolytic degradation of extracellular matrix. Biochem. Biophys. Res. Commun. 2004, 320, 256-261. [CrossRef]
  57. Bouzaiene, N.N.; Chaabane, F.; Sassi, A.; Chekir-Ghedira, L.; Ghedira, K. Effect of apigenin-7-glucoside, genkwanin and naringenin on tyrosinase activity and melanin synthesis in B16F10 melanoma cells. Life Sci. 2016, 144, 80–85. [CrossRef]
  58. Custódio, L.; Soares, F.; Pereira, H.; Rodrigues, M.J.; Barreira, L.; Rauter, A.P.; Alberício, F.; Varela, J. Botryococcus braunii and Nanochloropsis oculata extracts inhibit cholinesterases and protect human dopaminergic SH-SY5Y cells from H2O2-induced cytotoxicity. J. Appl. Phycol. 2015, 27, 839–848. [CrossRef]
  59. Zengin, G. A study on in vitro enzyme inhibitory properties of Asphodeline anatolica: new sources of natural inhibitors for public health problems. Ind. Crops Prod. 2016, 83, 39-43. [CrossRef]
  60. McDougall, G.J.; Kulkarni, N.N.; Stewart, D. Berry polyphenols inhibit pancreatic lipase activity in vitro. Food Chem. 2009, 115, 193–199. [CrossRef]
  61. Rodrigues, M.J.; Gangadhar, K.N.; Vizetto-Duarte, C.; Wubshet, S.G.; Nyberg, N.T.; Barreira, L.; Varela, J.; Custódio, L. Maritime halophyte species from southern Portugal as sources of bioactive molecules. Mar. Drugs 2014, 12, 2228–2244. [CrossRef]
Figure 1. Plants of sea mayweed (Tripleurospermum maritimum L.) on a maritime rocks (left) and grown in open field (right). (source : C. Magné).
Figure 1. Plants of sea mayweed (Tripleurospermum maritimum L.) on a maritime rocks (left) and grown in open field (right). (source : C. Magné).
Preprints 151386 g001
Figure 2. Total phenolic content (mg GAE.g-1 DW) of T. maritimum crude extract and fractions. RE, Raw extract; H2O, Water fraction; Me20, MeOH20 fraction; Me40, MeOH40 fraction; Me60, MeOH60 fraction; Me80, MeOH80 fraction; Me100, MeOH100 fraction; EtAc, Ethyl acetate fraction. Means ± standard deviations of three replicates are represented, and different letters above the bars indicate significantly different means (P<0.05).
Figure 2. Total phenolic content (mg GAE.g-1 DW) of T. maritimum crude extract and fractions. RE, Raw extract; H2O, Water fraction; Me20, MeOH20 fraction; Me40, MeOH40 fraction; Me60, MeOH60 fraction; Me80, MeOH80 fraction; Me100, MeOH100 fraction; EtAc, Ethyl acetate fraction. Means ± standard deviations of three replicates are represented, and different letters above the bars indicate significantly different means (P<0.05).
Preprints 151386 g002
Figure 3. Antioxidant activities of T. maritimum crude extract and fractions. A, ferric reducing capacity (EC50 in mg.mL-1); B, radical scavenging activity against DPPH (IC50 in mg.mL-1); C, radical scavenging activity against ABTS (mg TE.g-1 DW). RE, Raw extract; H2O, Water fraction; Me20, MeOH20 fraction; Me40, MeOH40 fraction; Me60, MeOH60 fraction; Me80, MeOH80 fraction; Me100, MeOH100 fraction; EtAc, Ethyl acetate fraction. Means ± standard deviations of three replicates are represented, and different letters above the bars indicate significantly different means (P<0.05).
Figure 3. Antioxidant activities of T. maritimum crude extract and fractions. A, ferric reducing capacity (EC50 in mg.mL-1); B, radical scavenging activity against DPPH (IC50 in mg.mL-1); C, radical scavenging activity against ABTS (mg TE.g-1 DW). RE, Raw extract; H2O, Water fraction; Me20, MeOH20 fraction; Me40, MeOH40 fraction; Me60, MeOH60 fraction; Me80, MeOH80 fraction; Me100, MeOH100 fraction; EtAc, Ethyl acetate fraction. Means ± standard deviations of three replicates are represented, and different letters above the bars indicate significantly different means (P<0.05).
Preprints 151386 g003
Figure 4. H1 NMR spectra of T. maritimum bioactive fractions eluted with water (A), 20% MeOH (B), 40% MeOH (C), 60% MeOH (D), 80% MeOH (E), 100% MeOH (F), and ethyl acetate (G). Stars in spectra B, C, and E indicate signals of fructo-oligosaccharide, 3,5-dicaffeoylquinic acid, and matricaria lactone, respectively. Specific signals of tripleurospermine (1) are indicated on spectrum C.
Figure 4. H1 NMR spectra of T. maritimum bioactive fractions eluted with water (A), 20% MeOH (B), 40% MeOH (C), 60% MeOH (D), 80% MeOH (E), 100% MeOH (F), and ethyl acetate (G). Stars in spectra B, C, and E indicate signals of fructo-oligosaccharide, 3,5-dicaffeoylquinic acid, and matricaria lactone, respectively. Specific signals of tripleurospermine (1) are indicated on spectrum C.
Preprints 151386 g004
Table 1. Anti-tyrosinase (diphenolase inhibition), anti-inflammatory (inhibition of NO production in RAW 264.7 macrophages), anti-melanogenic (inhibition of melanin production in RAW 264.7 macrophages), neuroprotective (acetylcholine esterase inhibition), and anti-diabetic (alpha-glucosidase inhibition) activities of sea mayweed polar extract and its fractions. Means ± SEM of three replicates are presented, and different letters indicate significantly different means (P<0.05). ND, not determined.
Table 1. Anti-tyrosinase (diphenolase inhibition), anti-inflammatory (inhibition of NO production in RAW 264.7 macrophages), anti-melanogenic (inhibition of melanin production in RAW 264.7 macrophages), neuroprotective (acetylcholine esterase inhibition), and anti-diabetic (alpha-glucosidase inhibition) activities of sea mayweed polar extract and its fractions. Means ± SEM of three replicates are presented, and different letters indicate significantly different means (P<0.05). ND, not determined.
Tyrosinase inhibition (mgKAE.g-1DW) Melanogenesis inhibition
(% at 125 μg.mL-1)
NO inhibition
(IC50, μg.mL-1)
AchE inhibition
(IC50, mg.mL-1)
Anti-α glucosidase
(IC50, mg.mL-1)
Raw extract
MeOH20
MeOH40
MeOH60
MeOH80
MeOH100
EtAc
Arbutin
L-NAME
Galantamine
Acarbose
294.29 ± 49.56c
178.42 ± 26.98d
452.59 ± 72.73b
527.89 ± 15.65b
472.92 ± 42.70b
707.52 ± 59.97a
719.67 ± 53.45a
ND
ND
ND
ND
ND
ND
23.77 ± 1.17b
15.95 ± 0.50a
ND
ND
ND
5.69 ± 0.30a
8.63 ± 0.55a
ND
103.17 ± 2.08c
 
27.81 ± 1.93b
ND
ND
ND
0.06 ± 0.00b
ND
ND
ND
 
 
0.01 ± 0.00a
ND
ND
0.20 ± 0.01 c
0.02 ± 0.00 a
0.57 ± 0.04 d
ND
0.06 ± 0.02 b
 
 
 
3.14 ± 0.09 e
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated